These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6388357)

  • 1. Abnormal coupling of insulin receptor binding in noninsulin-dependent diabetes.
    Mandarino LJ; Campbell PJ; Gottesman IS; Gerich JE
    Am J Physiol; 1984 Nov; 247(5 Pt 1):E688-92. PubMed ID: 6388357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
    Mandarino LJ; Gerich JE
    Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions.
    Bolli GB; Tsalikian E; Haymond MW; Cryer PE; Gerich JE
    J Clin Invest; 1984 Jun; 73(6):1532-41. PubMed ID: 6373827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
    Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus.
    Rizza RA; Mandarino LJ; Gerich JE
    Diabetes; 1981 Dec; 30(12):990-5. PubMed ID: 7030834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
    Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
    Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.
    Bogardus C; Lillioja S; Howard BV; Reaven G; Mott D
    J Clin Invest; 1984 Oct; 74(4):1238-46. PubMed ID: 6384267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss.
    Freidenberg GR; Reichart D; Olefsky JM; Henry RR
    J Clin Invest; 1988 Oct; 82(4):1398-406. PubMed ID: 3170749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.
    Kolterman OG; Gray RS; Griffin J; Burstein P; Insel J; Scarlett JA; Olefsky JM
    J Clin Invest; 1981 Oct; 68(4):957-69. PubMed ID: 7287908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of obesity on insulin action in NIDDM.
    Campbell PJ; Carlson MG
    Diabetes; 1993 Mar; 42(3):405-10. PubMed ID: 8432411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity.
    Nolan JJ; Freidenberg G; Henry R; Reichart D; Olefsky JM
    J Clin Endocrinol Metab; 1994 Feb; 78(2):471-7. PubMed ID: 8106637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.
    Kolterman OG; Insel J; Saekow M; Olefsky JM
    J Clin Invest; 1980 Jun; 65(6):1272-84. PubMed ID: 6997333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus.
    Kashiwagi A; Verso MA; Andrews J; Vasquez B; Reaven G; Foley JE
    J Clin Invest; 1983 Oct; 72(4):1246-54. PubMed ID: 6355180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
    Yki-Järvinen H; Taskinen MR; Kiviluoto T; Hilden H; Helve E; Koivisto VA; Nikkilä EA
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals.
    Potter van Loon BJ; Radder JK; Frölich M; Krans HM; Zwinderman AH; Meinders AE
    Int J Obes Relat Metab Disord; 1992 Feb; 16(2):79-85. PubMed ID: 1316330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
    Ward WK; Bolgiano DC; McKnight B; Halter JB; Porte D
    J Clin Invest; 1984 Oct; 74(4):1318-28. PubMed ID: 6384269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus.
    Campbell PJ; Mandarino LJ; Gerich JE
    Metabolism; 1988 Jan; 37(1):15-21. PubMed ID: 3275857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to insulin-mediated glucose disposal in patients with noninsulin-dependent diabetes mellitus in the absence of obesity or microalbuminuria--a Clinical Research Center study.
    Sheu W; Jeng CY; Fuh M; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1156-9. PubMed ID: 8772592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.